Circulating Tumour Cells
- All
- News
-
Nanoparticles May Promote Cancer Spread
The phenomenon, named 'nanomaterials induced endothelial leakiness' (NanoEL), accelerates the movement of cancer cells from the primary tumour and also causes circulating cancer cells to escape from blood circulation.
-
New Low-Cost 'Lab on a Chip' Has Potential to Detect Cancer
The lab on a chip has the potential to diagnose cancer early by detecting tumour cells that circulate in the bloodstream.
-
New Test to Quickly Spot Pancreatic Cancer: Study
By collecting samples from the portal vein -- which carries blood from the gastrointestinal tract, including from the pancreas, to the liver -- physicians can learn far more about a patients pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm, says a study.
-
Novel Drugs That Disguise as Human Platelets to Target Cancer
In a first, researchers have developed a technique that coats anti-cancer drugs as patient's own platelets, allowing the drugs to last longer and attack both primary tumours and the circulating tumour cells that can cause cancer to spread.
-
Nanoparticles May Promote Cancer Spread
The phenomenon, named 'nanomaterials induced endothelial leakiness' (NanoEL), accelerates the movement of cancer cells from the primary tumour and also causes circulating cancer cells to escape from blood circulation.
-
New Low-Cost 'Lab on a Chip' Has Potential to Detect Cancer
The lab on a chip has the potential to diagnose cancer early by detecting tumour cells that circulate in the bloodstream.
-
New Test to Quickly Spot Pancreatic Cancer: Study
By collecting samples from the portal vein -- which carries blood from the gastrointestinal tract, including from the pancreas, to the liver -- physicians can learn far more about a patients pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm, says a study.
-
Novel Drugs That Disguise as Human Platelets to Target Cancer
In a first, researchers have developed a technique that coats anti-cancer drugs as patient's own platelets, allowing the drugs to last longer and attack both primary tumours and the circulating tumour cells that can cause cancer to spread.
